194 related articles for article (PubMed ID: 6781658)
1. Cyclosporin A in cadaveric organ transplantation.
Calne RY; White DJ; Evans DB; Thiru S; Henderson RG; Hamilton DV; Rolles K; McMaster P; Duffy TJ; MacDougall BR; Williams R
Br Med J (Clin Res Ed); 1981 Mar; 282(6268):934-6. PubMed ID: 6781658
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A in patients receiving renal allografts from cadaver donors.
Calne RY; White DJ; Thiru S; Evans DB; McMaster P; Dunn DC; Craddock GN; Pentlow BD; Rolles K
Lancet; 1978 Dec 23-30; 2(8104-5):1323-7. PubMed ID: 82836
[TBL] [Abstract][Full Text] [Related]
3. The use of cyclosporin A and prednisone in cadaver kidney transplantation.
Starzl TE; Weil R; Iwatsuki S; Klintmalm G; Schröter GP; Koep LJ; Iwaki Y; Terasaki PI; Porter KA
Surg Gynecol Obstet; 1980 Jul; 151(1):17-26. PubMed ID: 6992310
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial.
Lancet; 1982 Jul; 2(8289):57-60. PubMed ID: 6123806
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.
Calne RY; Rolles K; White DJ; Thiru S; Evans DB; McMaster P; Dunn DC; Craddock GN; Henderson RG; Aziz S; Lewis P
Lancet; 1979 Nov; 2(8151):1033-6. PubMed ID: 91781
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.
Klintmalm GB; Iwatsuki S; Starzl TE
Lancet; 1981 Feb; 1(8218):470-1. PubMed ID: 6110092
[TBL] [Abstract][Full Text] [Related]
7. The use of cyclosporin A in clinical organ grafting.
Calne RY; White DJ
Ann Surg; 1982 Sep; 196(3):330-7. PubMed ID: 7051997
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of canine pancreas allograft survival with cyclosporin A: preliminary report.
McMaster P; Procyshyn A; Calne RY; Valdes R; Rolles K; Smith DJ
Br Med J; 1980 Feb; 280(6212):444-5. PubMed ID: 6989429
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A in clinical kidney grafting from cadaver donors.
Calne RY; White DJ; Thiru S; Evans DB; McMaster P; Dunn DC; Craddock GN; Rolles K
Proc Eur Dial Transplant Assoc; 1979; 16():305-9. PubMed ID: 398499
[No Abstract] [Full Text] [Related]
10. Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants.
Calne RY; White DJ; Pentlow BD; Rolles K; Syrakos T; Ohtawa T; Smith DP; McMaster P; Evans DB; Herbertson BM; Thiru S
Transplant Proc; 1979 Mar; 11(1):860-4. PubMed ID: 377719
[No Abstract] [Full Text] [Related]
11. Immunosuppression by Cyclosporin A in human renal transplant recipients.
Ringdén O; Bergstrand A; Collste H; Grimfors G; Lundgren G; Groth CG
Scand J Urol Nephrol Suppl; 1981; 64():220-9. PubMed ID: 6755683
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of the pancreas in man.
Brons G; Calne RY
Horm Metab Res Suppl; 1983; (13):81-4. PubMed ID: 6345325
[TBL] [Abstract][Full Text] [Related]
14. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
Fukuhara N; Ono Y; Hattori R; Nishiyama N; Yamada S; Kamihira O; Kinukawa T; Ohshima S
Clin Transplant; 2005 Apr; 19(2):153-7. PubMed ID: 15740548
[TBL] [Abstract][Full Text] [Related]
15. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A in organ transplantation.
Calne RY; Rolles K; White DJ; Thiru S; Evans DB; McMaster P; Dunn DC; Craddock GN; Henderson RG; Aziz S; Lewis P
Adv Nephrol Necker Hosp; 1981; 10():335-47. PubMed ID: 6791475
[No Abstract] [Full Text] [Related]
17. Organ allotransplantation since the advent of cyclosporin.
Du Toit DF; Heydenrych JJ; Laker L
S Afr Med J; 1985 Dec; 68(13):930-4. PubMed ID: 3936197
[TBL] [Abstract][Full Text] [Related]
18. Prolongation of intraperitoneal segmental pancreatic allografts in primates receiving cyclosporin A.
Du Toit DF; Heydenrych JJ; Louw G; Zuurmond T; Laker L; Els D; Weideman A; Wolfe-Coote S; Davids H
Surgery; 1984 Jul; 96(1):14-22. PubMed ID: 6377546
[TBL] [Abstract][Full Text] [Related]
19. Preliminary experience with cyclosporin A in human renal allografts.
Fernando ON; Sweny P; Farrington K; Rogers H; Baillod RA; Chan MK; Varghese Z; Moorhead JF
Transplant Proc; 1980 Jun; 12(2):244-5. PubMed ID: 6994292
[No Abstract] [Full Text] [Related]
20. Reversal of acute rejection episodes by cyclosporin A in dogs receiving renal allografts.
Homan WP; Fabre JW; French ME; Millard PR; Denton TG; Morris PJ
Transplantation; 1980 Mar; 29(3):262-3. PubMed ID: 6987793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
